News and Trends 8 Jan 2020 NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund the end of a phase IIb trial of its lead fatty acid drug to treat the liver condition NASH, as well as advancing two other drugs to clinical trials. There were two newcomers to the round: the US investor venBio […] January 8, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jan 2020 Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug Update (07/01/2020): Shanghai Miracogen has expanded its pre-existing license agreement with the Dutch biotech Synaffix. Under the terms of the new agreement, the Chinese pharma will use Synaffix’s antibody-drug conjugate technology to develop a second drug for the treatment of cancer. No financial details were disclosed. Published 10/04/2019: Shanghai Miracogen will pay up to €111M […] January 7, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2019 Dutch Startup Gets €9M to Create First Lab-Grown Pork Prototype Dutch startup Meatable has raised €9M in a seed round that will allow the company to host a tasting of its first prototype of lab-grown pork by summer 2020. The fundraising was led by the German VC BlueYard Capital, which had participated in Meatable’s previous €3M round last year. New investors include business angels Albert […] December 6, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 7 Nov 2019 Avantium Builds 10-Ton Demonstration Plant to Produce Bioplastics The Dutch bioplastics company Avantium has opened a demonstration plant capable of producing 10 tons per year of mono-ethylene glycol (MEG), a compound used to make plastics, using plants as the starting material. Construction of Avantium’s plant began at Chemie Park Delfzijl, the Netherlands, last year. The plant will extract carbohydrates from agricultural waste and […] November 7, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Oct 2019 Dutch Incubator Launched to Scale up Industrial Biotechs A collaboration involving the Dutch company DSM and other organizations in the Netherlands has launched Planet B.io, an incubator aimed at scaling up technology developed by industrial biotech startups such as the lab-grown meat developer Meatable. Planet B.io is based at the Biotech Campus Delft, the Netherlands, and contains a total of 3,000 m² of office […] October 14, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 11 Oct 2019 RNA Therapy Improves Vision in Untreatable Genetic Blindness A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the vision of people with Leber’s congenital amaurosis, a rare genetic disease for which there is no treatment. The RNA drug, called sepofarsen, is designed to treat people with a specific mutation in a gene […] October 11, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 20 Sep 2019 This Biotech Targets Mitochondria to Treat Inherited Diseases As we come to the end of the global Mitochondrial Disease Awareness Week, it’s time to visit Khondrion. This Dutch company is developing drugs to treat rare diseases such as MELAS syndrome by targeting defective mitochondria. Mission: To develop small molecule drugs able to treat Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) syndrome. This […] September 20, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2019 Dutch ‘Electronic Nose’ Predicts Cancer Immunotherapy Success A diagnostic device measuring chemicals in the breath, developed by the Dutch company Breathomix, was able to identify lung cancer patients that wouldn’t respond to cancer immunotherapy with unprecedented accuracy. Researchers at the University of Amsterdam tested the device on 143 lung cancer patients, who were going to receive immunotherapy in the form of the […] September 19, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 11 Sep 2019 Dutch Company Raises €60M to Treat Inherited Inflammatory Disease The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […] September 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jul 2019 Dutch-US Scientists Use Bacteria to Produce Graphene for Electronics An international group of researchers has made graphene more affordably and with a lower environmental impact than current chemical methods by using bacteria. Graphene is a very strong and conductive material that could revolutionize electronics and engineering. However, producing graphene in large quantities requires lots of energy and involves toxic chemicals, such as hydrazine, which […] July 15, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jul 2019 Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A The Dutch biotech Citryll has raised €15M to develop antibodies that could fight autoimmune and inflammatory diseases more effectively than current treatments by inhibiting the innate immune system. The Series A funds will be used to launch the clinical development of Citryll’s lead antibody, which is designed to treat the autoimmune condition lupus. The money […] July 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jun 2019 Scientists Grow Head and Neck Cancer Organoids to Personalize Chemotherapy A team of Dutch researchers has developed the first 3D organoids from patients’ head and neck cancer cells that can be kept alive for a long time, giving physicians a model to test which cancer treatments are the most effective for each patient. Head and neck cancer is an aggressive disease that often requires harsh […] June 19, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email